James Meer
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
Mr. James M.
Meer is a Chief Accounting Officer & Senior Vice President at Elanco Animal Health, Inc. Mr. Meer was previously employed as a Chief Financial Officer by Healthx, Inc., a Senior Vice President-Finance by Appirio, Inc., and a Vice President & Corporate Controller by ExactTarget Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/03/2026 | 66.732 ( 0,01 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Comptroller/Controller/Auditor | 24/09/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Healthx, Inc.
Healthx, Inc. Information Technology ServicesTechnology Services Provides healthcare information technology payer services | Director Financiero/CFO | 01/01/2018 |
Appirio, Inc.
Appirio, Inc. Packaged SoftwareTechnology Services Provides cloud consultancy services | Corporate Officer/Principal | 01/01/2017 |
| EXACTTARGET INC | Comptroller/Controller/Auditor | 01/01/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
ExactTarget LLC
ExactTarget LLC Information Technology ServicesTechnology Services Provides integrated software services | Technology Services |
Appirio, Inc.
Appirio, Inc. Packaged SoftwareTechnology Services Provides cloud consultancy services | Technology Services |
Healthx, Inc.
Healthx, Inc. Information Technology ServicesTechnology Services Provides healthcare information technology payer services | Technology Services |
Elanco Animal Health, Inc.
Elanco Animal Health, Inc. BiotechnologyHealth Technology Develops parasitic-ides, vaccines, therapeutics, medicated feed additives and injectable antibiotics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.